10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 65,080 | 0 | N/A |
| Receivables | 28,088 | 0 | N/A |
| Inventories | 8,570 | 0 | N/A |
| TOTAL | $106,236 | $0 | $N/A |
| Non-Current Assets | |||
| PPE Net | 11,127 | 0 | N/A |
| Other Non-Current Assets | 6,947 | 0 | 0 |
| TOTAL | $18,074 | $N/A | $N/A |
| Total Assets | $124,310 | $0 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 4,187 | 0 | N/A |
| Accounts payable and accrued liabilities | 8,792 | 0 | 0 |
| Accrued Expenses | 16,988 | 0 | N/A |
| TOTAL | $32,362 | $0 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 25,489 | 0 | N/A |
| Deferred Revenues | 2,395 | N/A | N/A |
| aiOther Non-Current Liabilities | 38,771 | 0 | 0 |
| TOTAL | $68,691 | $N/A | $N/A |
| Total Liabilities | $101,053 | $0 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 0 | N/A |
| Retained earnings | -231,116 | 0 | N/A |
| Other shareholders' equity | 243,207 | 0 | 0 |
| TOTAL | $23,257 | $0 | $N/A |
| Total Liabilities And Equity | $124,310 | $0 | $0 |